Developer docs
API playgroundTry for free, no card

Search company profiles

Imagen

Full company profile

uuid0000c4t

Namestring
Imagen
Legal namestring
Imagen Technologies, Inc.
Websiteurl
imagen.ai
Company typeenum
Private
Founded yearint
2015
Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
101–250
akta.pro rankint
HeadquartersNew York, United States
HQ citystring
New York
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
AI diagnostic imaging, radiology interpretation services, medical imaging AI, teleradiology platform, healthcare imaging analytics
NAICS code3 codes
  • Diagnostic Imaging Centers621512
  • Software Publishers5132
  • Navigational, Measuring, Electromedical, and Control Instruments Manufacturing33451
SIC code1 code
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
AI-Enabled Diagnostic Imaging Services
Social media profiles1 record
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model3 records
1Diagnostics as a Service (DaaS)
TypeManaged Services
Description

Comprehensive platform providing imaging equipment, technical staff, radiologists, imaging software, and proprietary FDA-cleared AI devices bundled together. No upfront costs to practices. Revenue generated through service delivery to provider organizations.

imagen.ai
2In-Clinic Imaging Services
TypeManaged Services
Description

Permanent, in-office imaging equipment and programs with end-to-end support including interpretation by board-certified specialists augmented by AI.

imagen.ai
3AI-Enabled Specialist Interpretations
TypeProfessional Services
Description

U.S.-based, sub-specialized clinician interpretations enabled with cutting-edge AI for improved accuracy, consistency, and timeliness.

imagen.ai
Marketing channels4 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales
Pricing details1 tier
1Custom enterprise pricing based on organizational needs
ModelOtherBilling cadenceMulti-year contract
Notes

Quote-based pricing tailored to provider organization's size, current service offerings, and patient profiles. No upfront capital investment required from practices.

imagen.ai
GTM typeB2B
B2B
Offering typeServices
Services
Brand1 of 6 records shown
1RadGap
Description

AI-enabled image and report analytics service that helps payers, providers, and other RBEs close care gaps

imagen.ai
+5 more records
Core offering1 text field

Imagen operates a Diagnostics as a Service (DaaS) platform that delivers AI-enabled diagnostic imaging to healthcare providers. The company bundles FDA-cleared deep-learning AI software, sub-specialized radiologist interpretations, in-office imaging equipment, technical staffing, and program support into a single offering delivered to independent practices, hospitals, and health systems with no upfront capital costs. Its portfolio of FDA-cleared AI devices (OsteoDetect, FractureDetect, ChestCAD, Aorta-CAD, Lung-CAD) targets fracture detection, chest X-ray abnormalities, aortic findings, and pulmonary conditions.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 9 values shown
  • 73% reduction in life-threatening clinical misses
+8 more records
Product and service8 records
1OsteoDetect
CategoryFDA-cleared AI software
Description

First-ever FDA-cleared software device for Radiological Computer Aided Detection (CADe) that uses AI to detect and localize distal radius fractures—the most commonly misdiagnosed musculoskeletal injury. In clinical study, clinicians experienced a 47% relative reduction in misinterpretation rate when aided by the software. Sold to healthcare provider organizations.

2FractureDetect
CategoryFDA-cleared AI software
Description

AI-enabled fracture detection software that detects hard-to-spot fractures throughout the musculoskeletal system across multiple X-ray views. Clinicians showed a 45% relative reduction in missed fractures when assisted by the software in clinical study. Sold to healthcare provider organizations.

3ChestCAD
CategoryFDA-cleared AI software
Description

AI software that detects, categorizes, and localizes suspicious regions on chest X-rays, trained on a proprietary dataset with labels comprehensively encompassing all abnormalities that can be screened for on a chest X-ray. Clinical study showed a 40% reduction in errors. Sold to healthcare provider organizations.

4Aorta-CAD
CategoryFDA-cleared AI software
Description

Cloud-based, software-only medical device using deep learning to detect and highlight findings associated with Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. Physicians showed a 62% relative reduction in misses for aortic calcification and 35% reduction for dilated aorta when assisted. Sold to healthcare provider organizations.

5Lung-CAD
CategoryFDA-cleared AI software
Description

AI software that detects and highlights radiographic findings of interstitial thickening and lung hyperinflation, suggestive of Pulmonary Fibrosis and COPD. Physicians showed a 48% relative reduction in misses of interstitial thickening and 40% reduction in lung hyperinflation when assisted. Sold to healthcare provider organizations.

6RadGap
CategoryAdvanced imaging analytics service
Description

AI-enabled image and report analytics service that helps payers, providers, and other risk-bearing entities (RBEs) close care gaps by identifying suspected care gaps and documentation errors across key conditions. Powered by computer vision AI, advanced NLP, and market-wide imaging access. Sold to payers, providers, and RBEs.

7In-Clinic Imaging
CategoryDiagnostic imaging service
Description

Permanent, in-office diagnostic imaging services with equipment, technical staffing, remote reads, accreditation support, EMR integration, and IT services embedded into existing provider workflows. Includes X-ray, mammography, ultrasound, echocardiography, CT, bone densitometry, spirometry, and more. Delivered to independent practices, hospitals, and health systems with no upfront capital costs.

8AI-Enabled Specialist Interpretations
CategoryRadiology interpretation service
Description

U.S.-based, fellowship-trained, sub-specialized clinician interpretations enabled with FDA-cleared AI for improved accuracy, consistency, and timeliness. Features board-certified radiologists, cardiologists, and sub-specialists providing sub-specialized reads with 99.5% on-time turnaround. Sold to provider organizations.

Scale indicator15 records

Each record includes

Type, Value, Description, Source

Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development Partner
Description

Imagen has partnered with top medical institutions, including several leading research hospitals, to design AI devices and curate training datasets. These partnerships enable access to diverse, high-quality medical imaging data and clinical expertise.

Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight6 records

Each record includes

Type, Description

Peers10 records
TypeEmerging player
Description

AI company with broad chest X-ray and CT triage/detection algorithms pursuing enterprise radiology deployments. Overlaps with Imagen's FDA-cleared chest X-ray and multi-modality AI ambitions.

TypeBroad incumbent
Description

One of the largest U.S. outpatient diagnostic imaging networks, operating hundreds of imaging centers and increasingly embedding AI into its workflow. Directly comparable to Imagen's DaaS model of providing imaging services to providers and patients, though at much larger scale and as an incumbent.

TypeDirect peer
Description

AI company offering FDA-cleared deep-learning algorithms for radiology workflow triage and detection across CT and X-ray. Overlaps directly with Imagen's FDA-cleared AI software portfolio and target customer base of hospitals and health systems.

TypeDirect peer
Description

AI-powered care coordination and image analysis platform focused on time-sensitive conditions (notably stroke). Comparable to Imagen as a venture-backed, FDA-cleared radiology AI company selling into hospital systems with workflow-integrated software.

TypeDirect peer
Description

AI imaging company with multiple FDA-cleared algorithms for chest X-ray, head CT, and lung nodule detection. Competes with Imagen in FDA-cleared chest X-ray AI and shares the enterprise radiology-AI go-to-market.

6Zebra Medical Vision (Nanox AI)
TypeDirect peer
Description

AI imaging analytics company (acquired by Nanox) offering FDA-cleared algorithms across multiple imaging modalities. Closely comparable to Imagen in building a portfolio of cleared radiology AI algorithms sold to provider organizations.

TypeBroad incumbent
Description

Global medical imaging equipment and informatics incumbent (PACS, AI orchestration, Edison platform) that bundles AI into its installed base. Comparable to Imagen as a broad imaging platform player whose offerings compete with Imagen's DaaS and AI capabilities for hospital budgets.

TypeBroad incumbent
Description

Major imaging equipment and informatics incumbent offering diagnostic imaging systems, PACS, and AI-driven clinical applications. Competes with Imagen across both the equipment layer of the DaaS model and AI-augmented interpretation.

TypeBroad incumbent
Description

U.S. outpatient diagnostic imaging networks providing in-clinic imaging services and teleradiology. Functionally comparable to Imagen's DaaS model of delivering imaging capacity to providers, though operating physical centers rather than embedding AI-native technology.

TypeEmerging player
Description

AI imaging company specializing in chest X-ray and CT image enhancement for earlier detection of lung and thoracic findings. Directly comparable to Imagen's ChestCAD and Lung-CAD products in cleared chest X-ray AI algorithms.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat6 records

Each record includes

Type, Details

Customer concentration

Classification, Details

Named customers2 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment4 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI capability3 records

Each record includes

Type, Description, Source

AI maturity
App detail

Has app

Feature6 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles7 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance3 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds4 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors9 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Imagen

AI-Enabled Diagnostic Imaging Servicesimagen.ai

Imagen firmographics

Firmographics
Name
Imagen
Legal name
Imagen Technologies, Inc.
Website
https://imagen.ai
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
101–250 employees
Ownership category
akta.pro rank

Where Imagen is headquartered

Location

Headquarters

HQ city
New York
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Imagen business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Personnel, Technology or R&D, Operations, Infrastructure, Marketing or Sales

Revenue model

  1. Diagnostics as a Service (DaaS): Comprehensive platform providing imaging equipment, technical staff, radiologists, imaging software, and proprietary FDA-cleared AI devices bundled together. No upfront costs to practices. Revenue generated through service delivery to provider organizations.
  2. In-Clinic Imaging Services: Permanent, in-office imaging equipment and programs with end-to-end support including interpretation by board-certified specialists augmented by AI.
  3. AI-Enabled Specialist Interpretations: U.S.-based, sub-specialized clinician interpretations enabled with cutting-edge AI for improved accuracy, consistency, and timeliness.

Pricing tiers

ModelBillingPrice
OtherMulti-year contractCustom enterprise pricing based on organizational needs

Go-to-market motion2 records

Distribution channels2 records

Marketing channels4 records

Imagen product offering

Product offering

Core offering

Imagen operates a Diagnostics as a Service (DaaS) platform that delivers AI-enabled diagnostic imaging to healthcare providers. The company bundles FDA-cleared deep-learning AI software, sub-specialized radiologist interpretations, in-office imaging equipment, technical staffing, and program support into a single offering delivered to independent practices, hospitals, and health systems with no upfront capital costs. Its portfolio of FDA-cleared AI devices (OsteoDetect, FractureDetect, ChestCAD, Aorta-CAD, Lung-CAD) targets fracture detection, chest X-ray abnormalities, aortic findings, and pulmonary conditions.

Differentiator

Problem solved

Functional benefit

Brands

  • RadGap: AI-enabled image and report analytics service that helps payers, providers, and other RBEs close care gaps
  • OsteoDetect
  • FractureDetect
  • ChestCAD
  • Aorta-CAD
  • Lung-CAD

Products and services

  • OsteoDetect First-ever FDA-cleared software device for Radiological Computer Aided Detection (CADe) that uses AI to detect and localize distal radius fractures—the most commonly misdiagnosed musculoskeletal injury. In clinical study, clinicians experienced a 47% relative reduction in misinterpretation rate when aided by the software. Sold to healthcare provider organizations.
  • FractureDetect AI-enabled fracture detection software that detects hard-to-spot fractures throughout the musculoskeletal system across multiple X-ray views. Clinicians showed a 45% relative reduction in missed fractures when assisted by the software in clinical study. Sold to healthcare provider organizations.
  • ChestCAD AI software that detects, categorizes, and localizes suspicious regions on chest X-rays, trained on a proprietary dataset with labels comprehensively encompassing all abnormalities that can be screened for on a chest X-ray. Clinical study showed a 40% reduction in errors. Sold to healthcare provider organizations.
  • Aorta-CAD Cloud-based, software-only medical device using deep learning to detect and highlight findings associated with Aortic Atherosclerosis and Aortic Ectasia on chest X-rays. Physicians showed a 62% relative reduction in misses for aortic calcification and 35% reduction for dilated aorta when assisted. Sold to healthcare provider organizations.
  • Lung-CAD AI software that detects and highlights radiographic findings of interstitial thickening and lung hyperinflation, suggestive of Pulmonary Fibrosis and COPD. Physicians showed a 48% relative reduction in misses of interstitial thickening and 40% reduction in lung hyperinflation when assisted. Sold to healthcare provider organizations.
  • RadGap AI-enabled image and report analytics service that helps payers, providers, and other risk-bearing entities (RBEs) close care gaps by identifying suspected care gaps and documentation errors across key conditions. Powered by computer vision AI, advanced NLP, and market-wide imaging access. Sold to payers, providers, and RBEs.
  • In-Clinic Imaging Permanent, in-office diagnostic imaging services with equipment, technical staffing, remote reads, accreditation support, EMR integration, and IT services embedded into existing provider workflows. Includes X-ray, mammography, ultrasound, echocardiography, CT, bone densitometry, spirometry, and more. Delivered to independent practices, hospitals, and health systems with no upfront capital costs.
  • AI-Enabled Specialist Interpretations U.S.-based, fellowship-trained, sub-specialized clinician interpretations enabled with FDA-cleared AI for improved accuracy, consistency, and timeliness. Features board-certified radiologists, cardiologists, and sub-specialists providing sub-specialized reads with 99.5% on-time turnaround. Sold to provider organizations.

Quantifiable outcome

  • 73% reduction in life-threatening clinical misses
  • +8 more outcomes

Companies that use Imagen

Customer profile

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Imagen technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

AI capability3 records

Feature6 records

Imagen partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • Top Medical Institutions and Research HospitalscoreStrategic or Co-development PartnerImagen has partnered with top medical institutions, including several leading research hospitals, to design AI devices and curate training datasets. These partnerships enable access to diverse, high-quality medical imaging data and clinical expertise.

Scale indicators15 records

Recent moves7 records

Expansion highlights6 records

Imagen competitors and assessment

Company assessment

Emerging players

  • Annalise.ai: AI company with broad chest X-ray and CT triage/detection algorithms pursuing enterprise radiology deployments. Overlaps with Imagen's FDA-cleared chest X-ray and multi-modality AI ambitions.
  • Riverain Technologies (ClearRead): AI imaging company specializing in chest X-ray and CT image enhancement for earlier detection of lung and thoracic findings. Directly comparable to Imagen's ChestCAD and Lung-CAD products in cleared chest X-ray AI algorithms.

Broad incumbents

  • RadNet: One of the largest U.S. outpatient diagnostic imaging networks, operating hundreds of imaging centers and increasingly embedding AI into its workflow. Directly comparable to Imagen's DaaS model of providing imaging services to providers and patients, though at much larger scale and as an incumbent.
  • GE HealthCare: Global medical imaging equipment and informatics incumbent (PACS, AI orchestration, Edison platform) that bundles AI into its installed base. Comparable to Imagen as a broad imaging platform player whose offerings compete with Imagen's DaaS and AI capabilities for hospital budgets.
  • Philips HealthSuite / Philips Imaging: Major imaging equipment and informatics incumbent offering diagnostic imaging systems, PACS, and AI-driven clinical applications. Competes with Imagen across both the equipment layer of the DaaS model and AI-augmented interpretation.
  • Akumin / US Radiology Specialists: U.S. outpatient diagnostic imaging networks providing in-clinic imaging services and teleradiology. Functionally comparable to Imagen's DaaS model of delivering imaging capacity to providers, though operating physical centers rather than embedding AI-native technology.

Direct peers

  • Aidoc: AI company offering FDA-cleared deep-learning algorithms for radiology workflow triage and detection across CT and X-ray. Overlaps directly with Imagen's FDA-cleared AI software portfolio and target customer base of hospitals and health systems.
  • Viz.ai: AI-powered care coordination and image analysis platform focused on time-sensitive conditions (notably stroke). Comparable to Imagen as a venture-backed, FDA-cleared radiology AI company selling into hospital systems with workflow-integrated software.
  • Qure.ai: AI imaging company with multiple FDA-cleared algorithms for chest X-ray, head CT, and lung nodule detection. Competes with Imagen in FDA-cleared chest X-ray AI and shares the enterprise radiology-AI go-to-market.
  • Zebra Medical Vision (Nanox AI): AI imaging analytics company (acquired by Nanox) offering FDA-cleared algorithms across multiple imaging modalities. Closely comparable to Imagen in building a portfolio of cleared radiology AI algorithms sold to provider organizations.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Customer concentration

Imagen social profiles

Digital presence

Imagen compliance and trust

Trust signal

Compliance3 records

Imagen financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Imagen leadership team

Management profile

Number of profiles

Profiles7 records

Imagen funding detail

Funding detail

Funding overview

Funding rounds4 records

Investors9 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Imagen M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Imagen

What does Imagen do?

Imagen operates a Diagnostics as a Service (DaaS) platform that delivers AI-enabled diagnostic imaging to healthcare providers. The company bundles FDA-cleared deep-learning AI software, sub-specialized radiologist interpretations, in-office imaging equipment, technical staffing, and program support into a single offering delivered to independent practices, hospitals, and health systems with no upfront capital costs. Its portfolio of FDA-cleared AI devices (OsteoDetect, FractureDetect, ChestCAD, Aorta-CAD, Lung-CAD) targets fracture detection, chest X-ray abnormalities, aortic findings, and pulmonary conditions.

Is Imagen a public or private company?

Imagen is a private company. It is classified as venture growth investor backed and is currently operating.

When was Imagen founded?

Imagen was founded in 2015. It employs 101 to 250 people.

Where is Imagen based?

Imagen is headquartered in New York, United States, in the North America region.

How does Imagen make money?

Three revenue lines are on record. Diagnostics as a Service (DaaS) is the primary driver. The others are in-Clinic Imaging Services and AI-Enabled Specialist Interpretations.

Who are Imagen's main competitors?

Emerging players on record are Annalise.ai and Riverain Technologies (ClearRead). Broad incumbents are RadNet, GE HealthCare, Philips HealthSuite / Philips Imaging and Akumin / US Radiology Specialists. Direct peers are Aidoc, Viz.ai, Qure.ai and Zebra Medical Vision (Nanox AI).

Does Imagen have an API?

No public API is recorded for Imagen.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
VentureburnImagen Raises $100 Million to Recruit Radiologists and Train AI ModelsImagen raised $100 million in growth capital to recruit radiologists and train AI models. The company employs over 230 radiologists and cardiologists and has secured up to 150 million imaging studies for model training. It interprets more than 2 million studies annually across 28 states.Unite.AIImagen Raises Over $100M in Growth Capital for Radiologists and AIImagen Technologies raised over $100 million in growth capital in 2026 and secured rights to up to 150 million additional imaging studies for AI training. The funds will support radiologist recruitment, with average year-over-year headcount growth of about 100%. The company plans to use the data to build and validate AI models for clinical workflows.Dealroom.coImagen raises $100M to recruit radiologists, train AI models | Dealroom NewsImagen Technologies raised $100 million in growth equity to recruit radiologists and train AI models. The New York-based radiology practice handles over 2 million imaging studies annually and plans to secure rights to 150 million additional studies for AI training.Radiology BusinessImaging group beefs up C-suite as radiologist roster hits 200 amid rapid growthImagen Technologies is expanding its C-suite leadership with new executive and medical appointments as the radiology practice reaches 200 physicians. The company, which operates across 28 states and utilizes proprietary AI technology, aims to support its rapid national expansion and clinical governance through these strategic hires.Business Wire BlogUnited States Artificial Intelligence in Diagnostics Market Research Report 2025-2033, Profiles of Siemens Healthineers, Riverain Technologies, Vuno, Aidoc, Neural Analytics, Imagen, GE, AliveCor - ReThe U.S. AI diagnostics market is projected to grow from $424.41 million in 2024 to $1.83 billion by 2033, a CAGR of 17.68%. Growth is driven by demand for early disease detection, AI algorithm advances, and integration with telemedicine, while regulatory and cost barriers remain.ThespinemarketgroupWhat is artificial intelligence Already Doing in the Spinal Field? Which AI Companies Are Worth Following?This article provides an overview of how artificial intelligence is being applied in spinal healthcare, covering five key areas: diagnosis and surgical planning, surgical navigation, outcome prediction, surgical robotics, and postoperative monitoring. Multiple companies are highlighted as leaders or active developers in these spaces, including Proprio, Siemens Healthineers, Imagen Technologies, Brainlab, Medtronic, Aidoc, and Katomed. The article also profiles several companies, noting that Proprio and Aidoc have distinct technological approaches (light field technology and FDA-cleared clinical AI respectively), while Katomed is described as an early-stage company actively fundraising.PR NewswireImagen Technologies Announces FDA Clearance of Aorta-CADImagen Technologies announced FDA 510(k) clearance for Aorta-CAD, a cloud-based AI device designed to assist physicians in detecting aortic atherosclerosis and aortic ectasia on chest X-rays. The device is the company's fourth FDA clearance and integrates into its Diagnostics as a Service platform to help primary care physicians diagnose and treat these chronic conditions earlier. Clinical trial data showed a 62% relative reduction in misses for aortic calcification and a 96% improvement rate among physicians assisted by the device.PR NewswireFDA permits marketing of artificial intelligence algorithm for aiding providers in detecting wrist fracturesThe U.S. Food and Drug Administration permitted marketing of Imagen OsteoDetect, an AI-powered computer-aided detection software designed to help healthcare providers identify distal radius wrist fractures in adult patients. The software uses machine learning algorithms to analyze two-dimensional X-ray images and highlights potential fracture locations. The FDA granted marketing authorization based on retrospective studies involving 1,000 radiograph images and 200 patient cases, which demonstrated improved detection sensitivity and accuracy when clinicians used the tool compared to unaided review.